The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 5276 -5282
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0801804

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heine, G.
Right arrow Articles by Worm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heine, G.
Right arrow Articles by Worm, M.

Liver X Receptors Control IgE Expression in B Cells1

Guido Heine2, Anja Dahten2, Kerstin Hilt, Dennis Ernst, Milena Milovanovic, Björn Hartmann and Margitta Worm3

Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany

B lymphocytes play a fundamental role in the development of IgE-dependent allergic immune reactions. Upon appropriate activation, IgE class switch recombination is initiated in B cells, followed by terminal differentiation to IgE-secreting plasmablasts. This process is controlled by different nuclear receptors, including receptors for vitamin D, retinoids, and peroxisome proliferator-activated receptor-{gamma} ligands. In this study, we show constitutive expression of the nuclear liver X receptor (LXR){alpha} and LXRβ in peripheral human B cells. Activation of LXRs reduced secreted IgE (–68% ± 11) in CD40 and IL-4 activated B cells. The production of other isotypes, including IgG, IgM, IgA and B cell homeostatic parameters were not significantly altered by LXR activation. We identified inhibitory action of LXR activation on IgE production involving reduced phosphorylation of JNK and increased membrane CD23 expression (38% ± 11). The biological significance of our findings was validated by showing that systemic treatment of type I-sensitized BALB/c mice with LXR ligands reduced the serum concentrations of Ag-specific IgE in a dose-dependent manner (maximum, –52% ± 14). Thus, our data indicates that LXRs are involved in the control of IgE secretion by differentiating B cells.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work is supported by the German Research Foundation (SFB650-TP5) and a grant of Charité Universitätsmedizin Berlin. G.H., A.D., and M.W. designed the experiments and largely wrote the manuscript, G.H., A.D., K.H., M.M., D.E., and B.H. performed and analyzed significant experimental procedures. All authors checked the final version of the manuscript.

2 G.H. and A.D. contributed equally to this work.

3 Address correspondence and reprint requests to Prof. Dr. Margitta Worm, Allergie-Centrum-Charité, Campus Charité Mitte, Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. E-mail address: margitta.worm{at}charite.de

4 Abbreviations used in this paper in this manuscript: LXR, liver X receptor; AID, activation-induced cytidine deaminase; {epsilon}GLT, {epsilon}-germline transcription; kgbw, kilogram body weight; sCD23, soluble CD23.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.